Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Adrenal & Rare Endocrine Cancers

Martin Fassnacht

马丁·法斯纳赫特

MD, PhD

🏢University Hospital Würzburg(维尔茨堡大学医院)🌐Germany

Professor and Head of Endocrinology and Diabetology内分泌与糖尿病科主任教授

62
h-index
3
Key Papers
2
Awards
3
Key Contributions

👥Biography 个人简介

Martin Fassnacht is a leading authority on adrenocortical carcinoma (ACC), coordinating the landmark FIRM-ACT trial that established EDP-M as a standard-of-care regimen. He chairs the European Network for the Study of Adrenal Tumors (ENSAT) and drives international ACC guidelines.

Share:

🧪Research Fields 研究领域

Adrenocortical Carcinoma肾上腺皮质癌
Mitotane Therapy米托坦治疗
Adrenal Tumors肾上腺肿瘤

🎓Key Contributions 主要贡献

FIRM-ACT Trial

Led the first randomized phase III trial in ACC, demonstrating superiority of EDP-M over streptozocin plus mitotane, defining the global chemotherapy standard for advanced disease.

Mitotane Optimization

Established therapeutic drug monitoring for mitotane and defined target plasma levels to maximize efficacy while managing toxicity in ACC patients.

ENSAT Registry & Guidelines

Built the European ENSAT database and co-authored international ACC management guidelines, enabling large-scale outcomes research across dozens of centers.

Representative Works 代表性著作

[1]

Combination Chemotherapy in Advanced Adrenocortical Carcinoma (FIRM-ACT)

New England Journal of Medicine (2012)

Landmark phase III RCT (n=304) establishing EDP-M as standard first-line chemotherapy for advanced ACC.

[2]

Management of Adrenocortical Carcinoma: European Society of Endocrinology Clinical Practice Guideline

European Journal of Endocrinology (2018)

Comprehensive evidence-based guideline covering diagnosis, staging, surgery, adjuvant therapy, and surveillance.

[3]

Prognostic Factors in Adrenocortical Carcinoma: A European Network for the Study of Adrenal Tumors Study

Journal of Clinical Oncology (2009)

Multi-center analysis identifying resection status and Ki-67 as key independent prognostic factors in ACC.

🏆Awards & Recognition 奖项与荣誉

🏆German Endocrine Society Award for Excellence in Clinical Research
🏆ENSAT Distinguished Investigator Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 马丁·法斯纳赫特 的研究动态

Follow Martin Fassnacht's research updates

留下邮箱,当我们发布与 Martin Fassnacht(University Hospital Würzburg)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment